About the initiative

This RFI will help to identify capacity and capability to support the manufacture, distribution and administration of COVID-19 vaccine and treatments within Australia. It will not include vaccine research and development capacity.

Why it is important

Having a complete understanding of production capacity and supply chains will help us identify facilities that could be repurposed, modified or expanded to make large quantities of a vaccine or other treatments.

Goals

Our goal is to build a complete picture of our ability to produce and supply large amounts of COVID-19 vaccine and treatments within Australia.

Meeting our goals

To make sure we have a full understanding of current capacity, the audit includes:

  • commercial vaccine manufacture
  • commercial treatment manufacture
  • fill and finish capabilities for vaccines and treatments
  • packaging and cold chain management for handling vaccines and treatments in safe temperature ranges
  • consumables, such as needles, vials and stoppers.

Who we work with

We have already collected information from:

Update on the audit

The RFI closed on 20 August 2020. We are looking at over 60 responses to identify companies that can produce COVID-19 vaccines and treatments in Australia.  Information from the RFI will be  provided to the COVID-19 Vaccines and Treatments for Australia – Science and Industry Technical Advisory Group.

Contact

COVID-19 Vaccine and Treatment Manufacturing Audit – Request for Information contact

Contact us for more information about the COVID-19 Vaccine and Treatment Manufacturing Audit – Request for Information.

COVID-19VaccineRFI [at] health.gov.au

View contact

Last updated: 
29 September 2020